Visual outcomes improved in patients who underwent treatment of meibomian gland dysfunction before cataract surgery, according to a study.
Refractive targets within 0.25 D and 0.5 D were achieved when LipiFlow thermal pulsation treatment (Johnson & Johnson Vision) was done preoperatively and surgical management was re-planned after the treatment.
“Forty percent of the time I needed to change my surgical plan, which was huge,” Cynthia A. Matossian, MD, FACS, said.
The pilot study, conducted by Matossian Eye Associates and presented at the American Society of Cataract and
Uncategorized